Natural compound tested to calm COVID's dangerous inflammation
NCT ID NCT04476953
Summary
This study is testing whether a drug called fisetin can help prevent hospitalized COVID-19 patients from getting sicker. Researchers want to see if it can reduce dangerous inflammation and help patients breathe easier without needing more oxygen or a ventilator. The trial includes 80 adults who are already in the hospital with a confirmed COVID-19 infection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.